PS995 IMPACT OF DNMT3A MUTATIONAL STATUS IN MOLECULAR MEASURABLE RESIDUAL DISEASE CLEARANCE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1

Autor: Jordi Esteve, Montserrat Arnan, Salut Brunet, Marta Pratcorona, Susana Vives, Olga Salamero, Rosa Coll, M.P. Queipo de Llano, Antoni Garcia, Alba Aljarilla, Guadalupe Oñate, Alex Bataller, J. Nomdedeu, Jordi Sierra, Ana Garrido

Publikováno v: HemaSphere. 3:447-448

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2c4435b09402fd98a9341f6a3ffdc44
https://doi.org/10.1097/01.hs9.0000562276.87064.96

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

Autor: J. Nomdedeu, Ruth M. Risueño, Marta Pratcorona, Carmen Pedro, Mar Tormo, M.P. Queipo de Llano, Meritxell Nomdedeu, Montserrat Arnan, Lourdes Escoda, Jordi Esteve, Alfons Navarro, Josep Martí, J. Bargay, S Brunet, Montserrat Hoyos, David Gallardo, Marina Díaz-Beyá, Olga Salamero, Anna Cordeiro, Josep-Maria Ribera, Antonia Sampol, Inmaculada Heras, Joan J. Castellano, Josep M. Sierra, Mariano Monzo

Publikováno v: Blood Cancer Journal
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (>= 60 years) with normal karyotype AML miR-3151 have been identif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b4c6c2c6e60b3178849b5975957796
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8303

MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia

Autor: Inmaculada Heras, M.P. Queipo de Llano, Marina Díaz-Beyá, Tania Díaz, Marta Pratcorona, Lourdes Escoda, Rafael F. Duarte, Jordi Esteve, Jordi Sierra, J. Bargay, Josep F. Nomdedeu, David Gallardo, Salut Brunet, Alfons Navarro, Josep-Maria Ribera, Rut Tejero, M Monzo, Mar Tormo

Publikováno v: LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Acute myeloid leukemia (AML) is a heterogeneous disease, and optimal treatment varies according to cytogenetic risk factors and molecular markers. Several studies have demonstrated the prognostic importance of microRNAs (miRNAs) in AML. Here we repor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234298bec3580a3a074e8b28aa0bf2d9
https://pubmed.ncbi.nlm.nih.gov/24072101

342 Effect of deferasirox on the immune response to invasive fungal infections in low risk MDS patients with iron overload

Autor: Arturo Campos, Isabel Caparrós, Laura Entrena, Regina Garcia, M.P. Queipo de Llano, S. Del Castillo, Ana Rosell, Gemma Ramirez, Alejandra Fernández, Agustin M Hernandez

Publikováno v: Leukemia Research. 35:S137

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f590987e7c53e953e92185c6437a5a82
https://doi.org/10.1016/s0145-2126(11)70344-7

342 Effect of deferasirox on the immune response to invasive fungal infections in low risk MDS patients with iron overload

Autor: Garcia, R., Hernandez, A., Fernandez, A.M., Rosell, A., de Llano, M.P. Queipo, Del Castillo, S., Campos, A., Caparros, I., Entrena, L., Ramirez, G.

Publikováno v: In Leukemia Research 2011 35 Supplement 1:S137-S137